Press and Announcements 

Regenerative medicine is a rapidly advancing area of medine providing the some of the most significant as it delivers Cellular Tissue Products, stimulating the body’s natural healing process by activating the body’s own ability to repair and regenerate. Innovative therapies are available that aid in healing or reconstruct damaged tissue and support the regeneration of injured cells and organs.  As press announcements become available on the company, the market or new products Olaregen will post announcements below to keep you current on these very important topics.  

Current Events - Press Releases - News and Science Information you shouldn't miss.

10/01/2019

Generex Biotechnology Corporation (GNBT), is pleased to announce that their subsidiary, Olaregen Therapeutix, Inc. today officially launched the Excellagen 3.0 cc pre-filled syringe.

09/30/2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Signs National Sales & Distribution Agreement With AvKare Medical to Distribute Excellagen® Throughout the VA Hospital System

07/15/2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors APMA Annual Scientific Meeting

07/12/2019

Generex Biotechnology Announces Closing on Acquisition of MediSource Partners

07/10/2019

Generex Biotechnology Provides Fiscal Year Overview

06/26/2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Receives American Podiatry Medical Associations “Seal of Approval” for Excellagen® Wound Conforming Matrix

05/16/2019

Generex Biotechnology Announces that its Subsidiary Olaregen Therapeutix Launches Excellagen® at The Symposium on Advanced Wound Care (SAWC) in San Antonio, TX

03/26/2019

Olaregen Therapeutix Inc. Selected to Present a Formal Poster Session at Prestigious Diabetic Limb Salvage Meeting..

03/08/2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Announces the Appointment of Vice President of Business Strategy

01/11/2019

Generex Biotechnology Subsidiary Olaregen Therapeutix Inc. Plans Launch of FDA Cleared…

01/8/2019

Generex Biotechnology Completes Acquisition of Olaregen Therapeutix Inc.

01/03/2019

Generex Biotechnology Partner Olaregen Therapeutix Inc. Signs Manufacturing Agreements for…

12/20/2018

Generex Biotechnology Partner Olaregen Therapeutix Inc. Establishes Sales Force and Distribution Team for

12/13/2018

Generex Biotechnology Partner Olaregen Therapeutix Sponsors Annual Meeting of Innovations in Wound…

11/28/2018

Generex Biotechnology Adds World-Class Leadership to Executive Management Team

11/28/2018

Generex Biotechnology Expands Medical Device Portfolio with Acquisition of Olaregen Therapeutix Inc

1001 6th Ave, 2nd Fl, New York, NY 10018
info@olaregen.com
1-844 -WOUNDS4

1001 6th Ave, 2nd Fl, New York, NY 10018
info@olaregen.com
1-844 -WOUNDS4